Fluorescein Isothiocyanate: A Novel Application for Lymphatic Surgery.

Ann Plast Surg

From the *Department of Surgery; †Division of Plastic and Reconstructive Surgery, Department of Surgery, University of Florida School of Medicine, Gainesville, FL; ‡Department of Plastic and Reconstructive Surgery, Lahey Clinic, Burlington, MA; §Department of Plastic and Reconstructive Surgery, China Medical University Hospital, China Medical University, Taichung, Taiwan; and ∥Division of Plastic and Reconstructive Surgery, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

Published: June 2017

The Lymphatic Microsurgical Preventing Healing Approach (LYMPHA) procedure entails performing a lymphovenous bypass (LVB) at the time of axillary lymph node dissection to reduce lymphedema risk. The two most common fluorophores utilized in LVB are blue dye and indocyanine green. We developed a novel application of fluorescein isothiocyanate for intraoperative lymphatic mapping. Our goal is to demonstrate the safety and efficacy of fluorescein isothiocyanate for this application. We reviewed a prospectively collected database on breast cancer patients who underwent LYMPHA from March to September 2015. Fluorescein isothiocyanate was used to identify arm lymphatic channels after axillary lymph node dissection to perform an LVB between disrupted lymphatics and axillary vein tributaries. Data on preoperative and intraoperative variables were analyzed. Thirteen patients underwent LYMPHA with intraoperative fluorescein isothiocyanate lymphatic mapping from March to September 2015. Average patient age was 50 years with a mean body mass index of 28. On average, 3.4 lacerated lymphatic channels were identified at an average distance of 2.72 cm (range, 0.25-5 cm) caudal to the axillary vein. On average, 1.7 channels were bypassed per patient. Eleven anastomoses were performed to the accessory branch of the axillary vein and 1 to a lateral branch. In 1 patient, a bypass was not performed due to poor lymphatic caliber and inadequate length of the harvested vein tributary. No intraoperative adverse events were noted. Fluorescein isothiocyanate is a safe and effective method for intra-operative lymphatic mapping. Fluorescein isothiocyanate imaging allows for simultaneous dissection and lymphatic visualization, making it an ideal agent for lymphatic mapping and dissection in open surgical fields, such as in the LYMPHA procedure.

Download full-text PDF

Source
http://dx.doi.org/10.1097/SAP.0000000000001034DOI Listing

Publication Analysis

Top Keywords

fluorescein isothiocyanate
28
lymphatic mapping
16
axillary vein
12
lymphatic
10
novel application
8
lympha procedure
8
axillary lymph
8
lymph node
8
node dissection
8
patients underwent
8

Similar Publications

Natural Epithelial Barrier Integrity Enhancers- and Extracts.

Gels

December 2024

The Department of Chemical Engineering and Biotechnology, Ariel University, Ariel 4070000, Israel.

Buccal drug delivery offers a promising alternative for avoiding gastrointestinal degradation and first-pass metabolism. However, enhancing the buccal epithelial barrier's permeability remains challenging. This study explores the effects of ethanolic extracts from (CM), (CMC), and (ORD) on buccal epithelium permeability in vitro using a TR146 cell-based model.

View Article and Find Full Text PDF

Aims: This study investigated the protective role of Annexin A1 (ANXA1) in sepsis-associated encephalopathy (SAE) by examining its effects on brain vascular endothelium and blood-brain barrier (BBB) integrity.

Methods: Mice were divided into four groups: wild type (WT), cecal ligation and puncture (CLP), ANXA1 knockout (ANXA1[-/-]), and ANXA1(-/-) with CLP. Neurobehavioral changes were assessed using the Y-maze test, while BBB integrity was evaluated through Evans blue dye (EBD) staining and permeability tests with fluorescein isothiocyanate (FITC)-dextran.

View Article and Find Full Text PDF

Sustained Release of RNA Nanoparticles from Reservoir Implant for Ocular Delivery.

J Pharm Sci

December 2024

Division of Pharmaceutical Sciences, College of Pharmacy, University of Cincinnati, Cincinnati, OH 45267. Electronic address:

Article Synopsis
  • RNA nanoparticles show promise for ocular delivery, particularly for chronic eye diseases, using a periocular reservoir implant like an episcleral implant.
  • The study aimed to create these implants, test their release performance with model substances and RNA nanoparticles, and apply hindered transport theory to analyze the release rates.
  • Findings showed that the release rates depended on both the size of the substances and the implant membrane's characteristics, indicating a potential for extended delivery of RNA nanoparticles through this implantation method.
View Article and Find Full Text PDF

Polymeric nanoparticles surface functionalised with fluorescent molecules hold significant potential for advancing diagnostics and therapeutic delivery. Despite their promise, challenges persist in achieving robust attachment of fluorescent molecules for real-time tracking. Weak physical adsorption, pH-dependent electrostatic capture, and hydrophobic interactions often fail to achieve stable attachment of fluorescent markers.

View Article and Find Full Text PDF

Atomically thin 2D materials present the potential for advancing membrane separations via a combination of high selectivity (from molecular sieving) and high permeance (due to atomic thinness). However, the creation of a high density of precise nanopores (narrow-size-distribution) over large areas in 2D materials remains challenging, and nonselective leakage from nanopore heterogeneity adversely impacts performance. Here, we demonstrate protein-enabled size-selective defect sealing (PDS) for atomically thin graphene membranes over centimeter scale areas by leveraging the size and reactivity of permeating proteins to preferentially seal larger nanopores (≥4 nm) while preserving a significant amount of smaller nanopores (via steric hindrance).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!